Abstract
Purpose
N2 lymph-node metastases occur in approximately 6–17% of the patients with T1-2 non-small cell lung cancer (NSCLC). However, the clinical characteristics of N2 patients are not fully understood.
Methods
This retrospective, multi-center analysis included T1 NSCLC patients receiving surgical resection during a period from Jan 2nd, 2014 to Dec 27th, 2017. The diagnosis was pathologically verified in all cases. Univariate and multivariate logistic regression analyses were conducted to analyze the factors that are associated with pN2 lymph-node metastases.
Results
A total of 10,885 patients (48.4% men; 84.7% adenocarcinoma) were included in the analysis. The mean age was 59.0 ± 9.9 years. The mean tumor size was 1.8 ± 0.8 cm. Of the patients, 3260 (29.9%) were smokers or ex-smokers. Lymph-node metastases were verified in 1808 (16.6%) patients, and 1167 (10.7%) patients had N2 lymph-node metastases. The multivariate analyses indicated that larger tumor size, lower differentiation, CEA level ≥ 5 ng/mL, vascular invasion (+), and pleural involvement (+) were associated with higher percentages of N2 lymph-node metastases (p < 0.001 for all).
Conclusions
This study demonstrated the significant association between N2 lymph-node metastases and tumor size and differentiation, CEA levels, and status of vascular invasion and pleural involvement.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Asamura H, Nakayama H, Kondo H, Tsuchiya R, Shimosato Y, Naruke T (1996) Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg 111:1125–1134
Bao F, Yuan P, Yuan X, Lv X, Wang Z, Hu J (2014) Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer. J Thorac Dis 6:1697–1703. https://doi.org/10.3978/j.issn.2072-1439.2014.11.05
Bertoglio P et al (2018) N2 lung cancer is not all the same: an analysis of different prognostic groups. Interact Cardiovasc Thorac Surg 27:720–726. https://doi.org/10.1093/icvts/ivy171
Birim O, Kappetein AP, Takkenberg JJ, van Klaveren RJ, Bogers AJ (2005) Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters. Ann Thorac Surg 79:1137–1141. https://doi.org/10.1016/j.athoracsur.2004.09.051
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Casali C, Stefani A, Natali P, Rossi G, Morandi U (2005) Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur J Cardiothorac Surg 28:33–38. https://doi.org/10.1016/j.ejcts.2005.03.016
Casiraghi M et al (2011) Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria? Eur J Cardiothorac Surg 39:e38–e43. https://doi.org/10.1016/j.ejcts.2010.11.059
Chen KZ, Yang F, Wang X, Jiang GC, Li JF, Wang J (2015) A clinical prediction model for N2 lymph node metastasis in clinical stage I non-small cell lung cancer. Beijing da Xue Xue Bao Yi Xue Ban 47:295–301
Cho HJ, Kim SR, Kim HR, Han JO, Kim YH, Kim DK, Park SI (2014) Modern outcome and risk analysis of surgically resected occult N2 non-small cell lung cancer. Ann Thorac Surg 97:1920–1925. https://doi.org/10.1016/j.athoracsur.2014.03.004
CSoCO (2018) Guidelines for the diagnosis and treatment of primary lung cancer [M]. People’ s Medical Publishing House, Beijing
Defranchi SA, Cassivi SD, Nichols FC, Allen MS, Shen KR, Deschamps C, Wigle DA (2009) N2 disease in T1 non-small cell lung cancer. Ann Thorac Surg 88:924–928. https://doi.org/10.1016/j.athoracsur.2009.05.039
Deng W et al (2018) Survival patterns for patients with resected N2 non-small cell lung cancer and postoperative radiotherapy: a prognostic scoring model and heat map approach. J Thorac Oncol 13:1968–1974. https://doi.org/10.1016/j.jtho.2018.08.2021
Goldstraw P et al (2016) The IASLC Lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 11:39–51. https://doi.org/10.1016/j.jtho.2015.09.009
Haager B, Wiesemann S, Passlick B, Schmid S (2018) Prognostic value of lymph node ratio after induction therapy in stage IIIA/N2 non-small cell lung cancer: a monocentric clinical study. J Thorac Dis 10:3225–3231. https://doi.org/10.21037/jtd.2018.05.138
Hamanaka R et al (2015) Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer. Diagn Pathol 10:17. https://doi.org/10.1186/s13000-015-0249-5
Hattori A et al (2012) Is limited resection appropriate for radiologically “solid” tumors in small lung cancers? Ann Thorac Surg 94:212–215. https://doi.org/10.1016/j.athoracsur.2012.03.033
Heon S, Yeap BY, Britt GJ, Costa DB, Rabin MS, Jackman DM, Johnson BE (2010) Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with Gefitinib or Erlotinib. Clin Cancer Res 16:5873. (An Official Journal of the American Association for Cancer Research)
Inoue M, Sawabata N, Takeda S, Ohta M, Ohno Y, Maeda H (2004) Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg 127:1100–1106. https://doi.org/10.1016/j.jtcvs.2003.09.012
Ishida T, Yano T, Maeda K, Kaneko S, Tateishi M, Sugimachi K (1990) Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg 50:708–713
Kim BT et al (2006) Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT–a prospective study. Radiology 241:501–509. https://doi.org/10.1148/radiol.2412051173
Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, Altorki NK (2007) Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 84:177–181. https://doi.org/10.1016/j.athoracsur.2007.03.081
Lochowski M, Lochowska B, Rebowski M, Brzezinski D, Cieslik-Wolski B, Kozak J (2018) Five-year survival analysis and prognostic factors in patients operated on for non-small cell lung cancer with N2 disease. J Thorac Dis 10:3180–3186. https://doi.org/10.21037/jtd.2018.05.173
Okada S et al (2017) Prognostic value of the frequency of vascular invasion in stage I non-small cell lung cancer. Gen Thorac Cardiovasc Surg 65:32–39. https://doi.org/10.1007/s11748-016-0720-6
Port JL, Kent MS, Korst RJ, Libby D, Pasmantier M, Altorki NK (2003) Tumor size predicts survival within stage IA non-small cell lung cancer. Chest 124:1828–1833
Qiang G et al (2015) Risk factors for recurrence after complete resection of pathological stage N2 non-small cell lung cancer. Thorac Cancer 6:166–171. https://doi.org/10.1111/1759-7714.12159
Seely JM, Mayo JR, Miller RR, Muller NL (1993) T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology 186:129–132. https://doi.org/10.1148/radiology.186.1.8416552
Shimada Y et al (2012) Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection. J Thorac Oncol 7:1263–1270. https://doi.org/10.1097/JTO.0b013e31825cca6e
Song Z, Ye T, Ma L, Xiang J, Chen H (2017) Surgical outcomes of isolated malignant pulmonary nodules in patients with a history of breast cancer. Ann Surg Oncol 24:3748–3753
Tamura M, Matsumoto I, Saito D, Yoshida S, Takata M, Takemura H (2016) Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer. World J Surg Oncol 14:295. https://doi.org/10.1186/s12957-016-1048-5
Xiong J, Wang R, Sun Y, Chen H (2016) Lymph node metastasis according to primary tumor location in T1 and T2 stage non-small cell lung cancer patients. Thorac Cancer 7:304–309. https://doi.org/10.1111/1759-7714.12328
Yu Y, Jian H, Shen L, Zhu L, Lu S (2016) Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤ 3 cm disease: A study of 2268 cases. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 42:1714–1719. https://doi.org/10.1016/j.ejso.2016.02.247
Zakaria N, Satar NA, Abu Halim NH, Ngalim SH, Yusoff NM, Lin J, Yahaya BH (2017) Targeting lung cancer stem cells: research and clinical impacts. Front Oncol 7:80. https://doi.org/10.3389/fonc.2017.00080
Zhang Y, Sun Y, Xiang J, Zhang Y, Hu H, Chen H (2012) A prediction model for N2 disease in T1 non-small cell lung cancer. J Thorac Cardiovasc Surg 144:1360–1364. https://doi.org/10.1016/j.jtcvs.2012.06.050
Zhang YK, Chai ZD, Tan LL, Wang ZY, Chen ZJ, Le HB, Zhu WY (2017) Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer. World J Surg Oncol 15:64. https://doi.org/10.1186/s12957-017-1098-3
Zheng D, Ye T, Hu H, Zhang Y, Sun Y, Xiang J, Chen H (2018) Upfront surgery as first-line therapy in selected patients with stage IIIA non–small cell lung cancer. J Thorac Cardiovasc Surg 155:1814–1822
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, B., Xia, W., Wang, Z. et al. Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China. J Cancer Res Clin Oncol 145, 2771–2777 (2019). https://doi.org/10.1007/s00432-019-03006-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-019-03006-x